Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation
This study shows that the supramolecular arrangement of proteins in nanoparticle structures predicts nanoparticle accumulation in neutrophils in acute lung inflammation (ALI). We observed homing to inflamed lungs for a variety of nanoparticles with agglutinated protein (NAPs), defined by arrangement...
Saved in:
Published in | Nature nanotechnology Vol. 17; no. 1; pp. 86 - 97 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.01.2022
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This study shows that the supramolecular arrangement of proteins in nanoparticle structures predicts nanoparticle accumulation in neutrophils in acute lung inflammation (ALI). We observed homing to inflamed lungs for a variety of nanoparticles with agglutinated protein (NAPs), defined by arrangement of protein in or on the nanoparticles via hydrophobic interactions, crosslinking and electrostatic interactions. Nanoparticles with symmetric protein arrangement (for example, viral capsids) had no selectivity for inflamed lungs. Flow cytometry and immunohistochemistry showed NAPs have tropism for pulmonary neutrophils. Protein-conjugated liposomes were engineered to recapitulate NAP tropism for pulmonary neutrophils. NAP uptake in neutrophils was shown to depend on complement opsonization. We demonstrate diagnostic imaging of ALI with NAPs; show NAP tropism for inflamed human donor lungs; and show that NAPs can remediate pulmonary oedema in ALI. This work demonstrates that structure-dependent tropism for neutrophils drives NAPs to inflamed lungs and shows NAPs can detect and treat ALI.
Neutrophils are the first responders in acute inflammatory events such as acute respiratory distress syndrome and tend to home to lung capillaries during acute inflammation, where they can cause tissue damage by diapedesis and secretion of specific molecules. Here the authors show that nanoparticles coated with agglutinated proteins selectively target activated neutrophils in inflamed lungs and can be used for imaging and therapeutic purposes. |
---|---|
Bibliography: | Author Contributions Statement J.W.M, P.N.P, N.H., L.R.W., D.C.L, Y.L., O.A.M., E.D.H., T.S., J.V.G., and J.N. designed and prepared nanoparticles used in the study. J.W.M., P.M.G., and R.Y.K. prepared E. coli for tracing in mice. J.W.M., P.N.P., L.R.W., O.A.M., L.L.M., P.M.G., I.J., J.N., and C.F.G. performed studies tracing nanoparticles in mice. J.W.M., P.N.P., M.H.Z., M.E.Z., J.W., and H.Z. performed studies of therapeutic efficacy. J.W.M., P.N.P., and L.T.F. performed studies tracing nanoparticles in human lungs. J.W.M., L.T.F. and K.M.R. performed studies tracing nanoparticle uptake in isolated cells. J.W.M., P.N.P., V.R.M., and J.S.B. analyzed all data. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. These authors contributed equally |
ISSN: | 1748-3387 1748-3395 |
DOI: | 10.1038/s41565-021-00997-y |